PEComa — Trials · CancerIndex

Clinical trials

Registered studies

62 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03817515	Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation	approved for marketing	—	—	Aadi Bioscience, Inc.INDUSTRY	0	Mar 16, 2022	clinicaltrials

Data updated 22 days agoSource updated Mar 16, 2022source: clinicaltrials